Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Gurusamy, Kurinchi Selvan ^a   Kumar, Yogesh ^b   Pamecha, Viniyendra ^a   Sharma, Dinesh ^a   Davidson, Brian R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

*Ischemic preconditioning; Blood loss, surgical *prevention control ; Constriction; Hepatectomy *methods; mortality ; Humans; Liver *blood supply ; Randomized controlled trials as topic; Reperfusion injury *prevention control

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CASPASE 3; PROTHROMBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL PRESSURE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT FISTULA; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD PRESSURE; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; BRAIN DISEASE; COCHRANE LIBRARY; ELECTIVE SURGERY; EMBASE; FATTY LIVER; HEART INDEX; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; INTENSIVE CARE UNIT; ISCHEMIC PRECONDITIONING; KIDNEY FAILURE; LENGTH OF STAY; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER INJURY; LIVER ISCHEMIA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LIVER VEIN; MEDLINE; MORBIDITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; REOPERATION; REPERFUSION INJURY; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SCISEARCH; SURGICAL MORTALITY; SYSTEMATIC REVIEW; SYSTEMIC VASCULAR RESISTANCE;

EID: 70249139820     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007629     Document Type: Review

References (52)

1. References to studies included in this review Azoulay 2006 {published data only} Azoulay D, Lucidi V, Andreani P, Maggi U, Sebagh M, Ichai P, et al.Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. Journal of the American College of Surgeons 2006;202(2):203-211 (Pubitemid 43112477)
2. Chouker 2004 {published and unpublished data} Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, et al.Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Archives of Surgery 2005;140(2):129-136 (Pubitemid 40229099)
3. Chouker A, Martignoni A, Schauer RJ, Dugas M, Schachtner T, Kaufmann I, et al.Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection. World Journal of Surgery 2005;29(4):528-534 (Pubitemid 41125382)
4. Chouker A, Martignoni A, Schauer RJ, Rau HG, Volk A, Heizmann O, et al.Ischemic preconditioning attenuates portal venous plasma concentrations of purines following warm liver ischemia in man. European Surgical Research 2005;37(3):144-152 (Pubitemid 41160146)
5. Chouker A, Schachtner T, Schauer R, Dugas M, Lohe F, Martignoni A, et al.Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. British Journal of Anaesthesia 2004;93(2):204-211 (Pubitemid 39117395)
6. Clavien 2003 {published and unpublished data} Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Annals of Surgery 2003;238(6):843-50; discussion 851-852 (Pubitemid 38174467)
7. Rudiger HA, Kang KJ, Selzner M, Selzner N, Dindo DR, Riehle HM, et al.Hepatic ischemic preconditioning is most effective in patients with a small resection volume and long ischemic intervals: a prospective randomized study in 100 patients. Journal of Hepatology 2002;36(Suppl):31-32
8. Rudiger HA, Selzner M, Dindo DR, Selzner N, Kadry Z, Clavien PA. Prospective randomized study in 100 consecutive patients undergoing major liver resection with vs without ischemic preconditioning. Hepatology 2002;36(4):173A.
9. Heizmann O, Loehe F, Volk A, Schauer RJ. Ischemic preconditioning improves postoperative outcome after liver resections: A randomized controlled study. European Journal of Medical Research 2008;13(2):79-86.
10. Jaeck D, Clavien PA, Starzl TE, Eggermont AMM, Makuuchi M, Tranberg KG, et al.A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning - Discussion. Annals of Surgery 2003;238(6):851-852
11. Ji XQ, Li CL, Yang JC, Liu XG, Wang ML, Liu ZQ, et al.[Application of ischemic preconditioning before hepatic vascular exclusion for resection of hepatocellular carcinoma]. Di Yi Jun Yi Da Xue Xue Bao [Academic Journal of the First Medical College of PLA] 2004;24(1):66-8, 71.
12. Liang L, Li S, Huang J. [The protective effect and mechanism of ischemic preconditioning for hepatic resection under hepatic blood inflow occlusion in hepatocellular carcinoma patients with cirrhosis]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery] 2002;40(4):265-267
13. Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World Journal of Gastroenterology 2004;10(17):2580-2584 (Pubitemid 39206785)
14. Nuzzo 2004 {published data only} Nuzzo G, Giuliante F, Vellone M, De Cosmo G, Ardito F, Murazio M, et al.Pedicle clamping with ischemic preconditioning in liver resection. Liver Transplantation 2004;10(2 Suppl 1):S53-S57. (Pubitemid 38240101)
15. Schauer R, Rau HG, Kessler M, Schildberg FW. Ischemic preconditioning as a possibility for attenuating reperfusion injury after liver resection: a pilot study. Deutsche Gesellschaft fur Chirurgie 1999;Suppl Kongressband II:1239-1241
16. Additional references Balzan 2005 Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al.The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Annals of Surgery 2005;242(6):824-828 (Pubitemid 41714060)
17. Banga 2005 Banga NR, Homer-Vanniasinkam S, Graham A, Al-Mukhtar A, White SA, Prasad KR. Ischaemic preconditioning in transplantation and major resection of the liver. British Journal of Surgery 2005;92(5):528-538 (Pubitemid 40685646)
18. Belghiti 1993 Belghiti J, Kabbej M, Sauvanet A, Vilgrain V, Panis Y, Fekete F. Drainage after elective hepatic resection. A randomized trial. Annals of Surgery 1993;218(6):748-753 (Pubitemid 24005819)
19. Clavien 2000 Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Annals of Surgery 2000;232(2):155-162 (Pubitemid 30616712)
20. Couinaud 1999 Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Digestive Surgery 1999;16(6):459-467 (Pubitemid 30072153)
21. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-350
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-188
23. Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-634 (Pubitemid 27387172)
24. Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2008, Issue 1. Art. No.: LIVER.
25. Gurusamy KS, Kumar Y, Ramamoorthy R, Sharma D, Davidson BR. Vascular occlusion for elective liver resections. Cochrane Database of Systematic Reviews 2009, Issue 1. [Art. No.: CD007530. DOI: 10.1002/14651858.CD007530]
26. Gurusamy 2009b Gurusamy KS, Sheth H, Kumar Y, Sharma D, Davidson BR. Methods of vascular occlusion for elective liver resections. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007632] (Pubitemid 351824571)
27. Hospital Episode Statistics. Main operations. 3 character: 2004-2005 http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID= 1937&categoryID=205 (accessed 17 April 2007).
28. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-1558
29. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention 5.0.0 [updated February 2008]. The Cochrane Colloboration, 2008. Available from www.cochrane-handbook.org.
30. Ibrahim 2006 Ibrahim S, Chen CL, Lin CC, Yang CH, Wang CC, Wang SH, et al.Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy. Liver Transplantation 2006;12(6):950-957 (Pubitemid 43960371)
31. Kanoria 2006 Kanoria S, Jalan R, Davies NA, Seifalian AM, Williams R, Davidson BR. Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemia-reperfusion injury. The British Journal of Surgery 2006;93(6):762-768 (Pubitemid 43886031)
32. Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-989 (Pubitemid 33131619)
33. Koti 2003 Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Digestive Surgery 2003;20(5):383-396 (Pubitemid 37116937)
34. Macaskill 2001 Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-654 (Pubitemid 32166424)
35. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-613 (Pubitemid 28380142)
36. Mullen 2007 Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al.Hepatic insufficiency andmortality in 1,059 noncirrhotic patients undergoing major hepatectomy. Journal of the American College of Surgeons 2007;204(5):854-862 (Pubitemid 46661186)
37. the National Center for Biotechnology Information. MeSH. Ischemic preconditioning. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=mesh&list-uids=68019194&dopt=Full (accessed 17 April 2007).
38. The National Center for Biotechnology Information. MeSH. Apoptosis. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= mesh&list-uids=68017209&dopt=Full (accessed 17 April 2007).
39. The National Center for Biotechnology Information. Entrez Protein. NP 004337. caspase 3 preproprotein [Homo sapiens]. Comment. http://www.ncbi.nlm. nih.gov/entrez/viewer.fcgi?db=protein&val=14790119 (accessed 17 April 2007).
40. Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837-841
41. Pringle J. Notes on the arrest of hepatic hemorrhage due to trauma. Annals of Surgery 1908;48(4):541-549
42. Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall E, et al.Systematic review andmeta-analysis of the effect of portal triad clamping on outcome after hepatic resection. The British journal of surgery 2008;95(4):424-432 [PUBMED: 18314921]
43. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
44. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603. (Pubitemid 38405633)
45. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-412
46. Shimada 1998 Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, et al.Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. The British Journal of Surgery 1998;85(2):195-198 (Pubitemid 28099936)
47. Strasberg SM, Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, et al.The Brisbane 2000 terminology of liver anatomy and resections. HPB Surgery 2000;2(3):333-339
48. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine 2004;23(9):1351-1375
49. van den Broek 2008 van den Broek MA, Damink SW, Dejong CH, Lang H, Malago M, Jalan R, et al.Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver International 2008;28(6):767-780 (Pubitemid 351818638)
50. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical research ed.) 2008;336(7644):601-605 [PUBMED: 18316340]
51. Yoshimura 2004 Yoshimura Y, Kubo S, Shirata K, Hirohashi K, Tanaka H, Shuto T, et al.Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World Journal of Surgery 2004;28(10):982-986 (Pubitemid 40109881)
52. References to other published versions of this review Gurusamy 2007 Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Methods of vascular occlusion for elective liver resections. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006409. [DOI: 10.1002/14651858] (Pubitemid 351824571)